BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1984075)

  • 21. [pT1G3 tumor of the bladder].
    Vicini D; Bettaglio G; Dallera P; Ruggieri M; Mirando P; Franceschetti GP; Sali C; Picchio GL
    Arch Ital Urol Androl; 1996 Feb; 68(1):61-5. PubMed ID: 8664925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.
    Kluth LA; Xylinas E; Crivelli JJ; Passoni N; Comploj E; Pycha A; Chrystal J; Sun M; Karakiewicz PI; Gontero P; Lotan Y; Chun FK; Fisch M; Scherr DS; Shariat SF
    J Urol; 2013 Aug; 190(2):480-6. PubMed ID: 23376707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is your diagnosis? Transitional cell carcinoma in the bladder of a dog.
    Bufkin BW; Henderson RA; Beard DM; Smith AN
    J Am Vet Med Assoc; 2009 Dec; 235(12):1403-4. PubMed ID: 20001771
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcification in uroepithelial tumors of the bladder. Report of 5 cases and survey of the literature.
    Miller SW; Pfister RC
    Am J Roentgenol Radium Ther Nucl Med; 1974 Aug; 121(4):827-31. PubMed ID: 4432962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of transitional cell carcinoma of the bladder.
    Murshidi MS
    Arch Esp Urol; 1989 Mar; 42(2):172-5. PubMed ID: 2735783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current status of the treatment of urothelial tumors].
    Akaza H
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):205-11. PubMed ID: 3341782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Our experience in treating patients with surface cancer of the bladder].
    Matveev BP; Figurin KM; Romanov VA; Cheban NL
    Urol Nefrol (Mosk); 1995; (5):35-8. PubMed ID: 8571484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [pT1G3 bladder carcinoma: our experience].
    Dell'Orto P; Trinchieri A; D'Addezio F; Bernardini P; Mangiarotti B; Del Nero A; Pisani E
    Arch Ital Urol Androl; 1996 Feb; 68(1):9-11. PubMed ID: 8664927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperthermic treatment for the bladder tumor. I. Clinical study (author's transl)].
    Kishimoto T; Okada K; Takimoto Y; Kitajima K; Kumagai S
    Nihon Hinyokika Gakkai Zasshi; 1975 Aug; 66(8):485-92. PubMed ID: 1238845
    [No Abstract]   [Full Text] [Related]  

  • 30. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy.
    Prout GR; Shipley WU; Kaufman DS; Heney NM; Griffin PP; Althausen AF; Bassil B; Nocks BN; Parkhurst EC; Young HH
    J Urol; 1990 Nov; 144(5):1128-34; discussion 1134-6. PubMed ID: 2122007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical image. Cystolithic lithuresis.
    Grant L
    N Z Med J; 2004 Nov; 117(1206):U1191. PubMed ID: 15570354
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current status of the conservative treatment of urinary bladder for invasive bladder cancer].
    Ueda K; Sakagami H; Kato F; Mogami T; Ohtaguro K
    Hinyokika Kiyo; 1991 Dec; 37(12):1597-9. PubMed ID: 1785380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incrustation and uptake of skeletal imaging agent in transitional cell carcinoma.
    Taniguchi M; Tatsuta N; Yokota H; Ouguchi M; Higashi K; Okimura T; Yamamoto I
    J Nucl Med; 1997 Aug; 38(8):1206-7. PubMed ID: 9255150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urothelial carcinoma with abundant myxoid stroma.
    Tavora F; Epstein JI
    Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous urography in the follow-up of carcinoma of the bladder.
    Booth CM; Kellett MJ
    Br J Urol; 1981 Jun; 53(3):246-9. PubMed ID: 7248702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined radiosurgical treatment of bladder carcinoma: preliminary results of a prospective trial.
    Salvi G; Balducci M; Cellini N; D'Andrea P; De Santis M; Valentini V; Romanini A
    Rays; 1985; 10(3):133-9. PubMed ID: 3843662
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy and follow-up of bladder cancer].
    Meyer D; Schmid HP; Engeler DS
    Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic Resonance Imaging Evaluation of Urothelial Cell Carcinoma: Histopathological Correlation, Staging, and Treatment Planning.
    Harri PA; Alexander L; Camacho JC; Moreno CC; Mittal P
    Curr Probl Diagn Radiol; 2018; 47(1):28-41. PubMed ID: 28571907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.